OTCMKTS:CDXI Cardax (CDXI) Stock Price, News & Analysis Add Compare Share Share Stock Analysis Stock AnalysisChart About Cardax Stock (OTCMKTS:CDXI) Get Cardax alerts:Sign Up Key Stats Today's Range N/A50-Day Range N/A52-Week Range N/AVolumeN/AAverage VolumeN/AMarket CapitalizationN/AP/E RatioN/ADividend YieldN/APrice TargetN/AConsensus RatingN/A Company Overview Cardax, Inc. (OTCMKTS:CDXI) is a clinical-stage biotechnology company focused on the discovery and development of novel anti-inflammatory drug candidates. The company’s proprietary platform utilizes phospholipid-conjugated formulations of astaxanthin designed to enhance bioavailability and target chronic inflammatory and fibrotic conditions. Cardax’s lead program, CARD-024, is advancing in preclinical development for the treatment of atherosclerosis and related cardiovascular diseases. In addition to its cardiovascular pipeline, the company is exploring immuno-oncology and gastrointestinal indications, leveraging its core technology to create differentiated therapeutic assets across multiple disease areas. Headquartered in Honolulu, Hawaii, Cardax conducts its research and development activities primarily within the United States. The management team combines expertise in pharmaceutical sciences, clinical operations and regulatory affairs, positioning the company to progress its candidates through critical preclinical and early clinical milestones.AI Generated. May Contain Errors. Read More Receive CDXI Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Cardax and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. CDXI Stock News HeadlinesCardax Inc.December 14, 2025 | wsj.comCardiometabolic Disease Market Size Worth USD 868.45 Billion by 2032 at 24% CAGR – Report by Market Research Future (MRFR)June 2, 2023 | finance.yahoo.comYour book attachedBill Poulos is giving away his 'Safe Trade Options Formula' book for free - but only for a limited time through a temporary download link. He plans to charge for it soon. Download your copy now and lock it in at no cost, regardless of future pricing.September 15 at 1:00 AM | Profits Run (Ad)CDXI.PK - Cardax Inc | Stock Price & Latest News | ReutersOctober 10, 2022 | reuters.comCardax, Inc. (CDXI)October 4, 2022 | finance.yahoo.comCDXI After-Hours QuotesJanuary 20, 2022 | nasdaq.comCardax Inc. makes several moves to reduce costsSeptember 2, 2021 | news.yahoo.comCardax Refocuses on ZanthoSyn® Consumer Health BusinessAugust 31, 2021 | finance.yahoo.comSee More Headlines CDXI Stock Analysis - Frequently Asked Questions How do I buy shares of Cardax? Shares of CDXI stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of Cardax own? Based on aggregate information from My MarketBeat watchlists, some other companies that Cardax investors own include Ashford Hospitality Trust (AHT), Peabody Energy (BTU), Assertio (ASRT), Astronics (ATRO), Alliance Resource Partners (ARLP). Company Calendar Today9/15/2026Fiscal Year End12/31/2026Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeOTCMKTS SectorHealthcare Industry Pharmaceuticals Sub-IndustryPharmaceuticals Current SymbolOTCMKTS:CDXI CIK1544238 Webwww.cardaxpharma.com Phone(808) 457-1400Fax808-237-5901Employees10Year Founded2006Profitability EPS (Trailing Twelve Months)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding Shares800,000Free Float566,000Market CapN/A OptionableNot Optionable BetaN/A Social Links Don't Wait for the OpenAI IPOThe AI wave will soon hit public markets with Anthropic and OpenAI set to go public later this year. However, you don't have to wait to invest. This report shows seven AI stocks that you can buy today while the big model providers get ready to go public.Get This Free Report This page (OTCMKTS:CDXI) was last updated on 9/15/2026 by MarketBeat.com Staff. From Our PartnersALERT: Drop these 5 stocks before the market opens tomorrow!The Wall Street Journal is already raising the alarm about a potential market crash, and Weiss Ratings researc...Weiss Ratings | SponsoredSmall Colorado Company (Backed by Sam Altman) Could Save U.S. Power GridA small Colorado company has secured rights to technology that could prevent the U.S. public power grid from c...Altimetry | SponsoredLouis Navellier: My #1 AI stock for 2026 (name & ticker inside)Louis Navellier's Stock Grader system helped him flag Nvidia before its 82,000% run and has identified the top...InvestorPlace | SponsoredReady to give options a try? Your first trade (Ticker included) -INSIDETired of trying tactic after tactic when it comes to options trades... only to be met with market noise and st...Base Camp Trading | SponsoredHere’s the stock symbol I’ve promisedWhitney Tilson of Stansberry Research has long recommended Berkshire Hathaway as a core retirement holding - b...Stansberry Research | SponsoredThese gold assets are priced for $1,800 gold [it's over $4,000]Gold's major miners are generating record free cash flow, with margins as high as 75 percent even after gold's...Golden Portfolio | SponsoredYour book is insideThe "Sucker's Bet" Most New Options Traders Fall For Most people who try options lose money the same way. ...Profits Run | SponsoredYour withdrawal order could cost you in taxesIf you have $2M or more saved, the 4% rule points to roughly $92,000 a year - but it's a single-variable answe...SmartAsset | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Cardax, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Cardax With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free CDXI Stock Alerts